DIMERIX LIMITED
ASX:DXBPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 96.0% of what they think they own, once every option and right converts.
Runway under 2 quarters; share count grew 8% in 24 months
DIMERIX LIMITED's ordinary share count increased 7.7% between October 2024 and October 2025, its latest share-count filing, to 600M shares. In the 24-month window, it has not raised capital through any placement, rights issue or share purchase plan. Options and rights could convert into 25M new shares, representing 4.1% of the current share count; none are in the money, and no expiry date for these securities is on record. The company has under 2 quarters of funding at the recent spend rate. No proposed securities issues are pending.
Quick answers · 4
How much placement capacity does DXB have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does DXB have?
In its quarterly cash report for the quarter ended 30 June 2026, Dimerix reported $16.2M of cash and estimated 1.5 quarters of funding available at its current rate of spending. That is the company's own estimate.
How many options and rights does DXB have outstanding?
Unexercised options and rights equal 4.1% of Dimerix's shares on issue.
How much has DXB's share count grown?
Dimerix has 600.4M shares on issue as at 28 Oct 2026, up 7.7% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 28 Sept 2026 | 3G · unquoted | ORDINARY FULLY PAID | 600.4M | Appendix 3G |
| 12 Dec 2025 | 3G · unquoted | DXB : ORDINARY FULLY PAID | 600.4M | Appendix 3G |
| 22 Oct 2025 | 2A · quoted issue | DXB : ORDINARY FULLY PAID | 600.4M | Appendix 2A |
| 12 Aug 2025 | 2A · quoted issue | DXB : ORDINARY FULLY PAID | 600.2M | Appendix 2A |
| 1 July 2025 | 2A · quoted issue | DXB : ORDINARY FULLY PAID | 600.1M | Appendix 2A |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 24.9M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| DXBAX | Options | Price-triggered, no exercise price stated | — | — | 24.9M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 12 Dec 2025 | Clinton Snow | Other incentive | — | 300k | — | $96k | 3Y notice |
| 12 Dec 2025 | Hugh Alsop | Other incentive | — | 300k | — | $96k | 3Y notice |
| 12 Dec 2025 | Mark Diamond | Other incentive | — | 300k | — | $96k | 3Y notice |
| 12 Dec 2025 | Nina Webster | Other incentive | 123k | 3.3M | — | $1.1M | 3Y notice |
| 12 Dec 2025 | Sonia Poli | Other incentive | 633k | 300k | — | $96k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.